{
    "SLC22A8": {
        "expression": [
            {
                "Organ": "Brain",
                "Source": "Nishimura",
                "Relative Expression": "0.000504"
            },
            {
                "Organ": "Kidney*",
                "Source": "Nishimura",
                "Relative Expression": "0.818"
            },
            {
                "Organ": "Liver",
                "Source": "Nishimura",
                "Relative Expression": "0.000135"
            },
            {
                "Organ": "Placenta",
                "Source": "Nishimura",
                "Relative Expression": "BLQ"
            },
            {
                "Organ": "Small Intestine",
                "Source": "Nishimura",
                "Relative Expression": "BLQ"
            },
            {
                "Organ": "Kidney*",
                "Source": "Mean across all PMT Samples",
                "Relative Expression": "17.974"
            },
            {
                "Organ": "Liver",
                "Source": "Mean across all PMT Samples",
                "Relative Expression": "BLQ"
            }
        ],
        "inhibitors": [
            {
                "Inhibitor": "(Noradamantan-3-yl)-1,3-dipropylxanthine (KW-3902)",
                "IC50 (μM)": null,
                "Ki (μM)": 3.7,
                "Substrate used": "Estrone 3-sulfate",
                "Cell System": "S2-OAT3",
                "Reference": "Takeda, 2001"
            },
            {
                "Inhibitor": "1-butanesulfonic acid (BSA)",
                "IC50 (μM)": 5098.0,
                "Ki (μM)": null,
                "Substrate used": "Estrone 3-sulfate",
                "Cell System": "CHO-OAT3",
                "Reference": "Astorga, 2011"
            },
            {
                "Inhibitor": "2,3-Dimercapto-1-propane sulfonate (DMPS)",
                "IC50 (μM)": 40.0,
                "Ki (μM)": null,
                "Substrate used": "Estrone 3-sulfate",
                "Cell System": "CHO-OAT3",
                "Reference": "Astorga, 2011"
            },
            {
                "Inhibitor": "3-mercapto-1-propansulfonic acid (MPS)",
                "IC50 (μM)": 2139.0,
                "Ki (μM)": null,
                "Substrate used": "Estrone 3-sulfate",
                "Cell System": "CHO-OAT3",
                "Reference": "Astorga, 2011"
            },
            {
                "Inhibitor": "Acetazolamide",
                "IC50 (μM)": 816.0,
                "Ki (μM)": null,
                "Substrate used": "Estrone 3-sulfate",
                "Cell System": "S2-OAT3",
                "Reference": "Hasannejad, 2004"
            },
            {
                "Inhibitor": "Adipate",
                "IC50 (μM)": 136.0,
                "Ki (μM)": null,
                "Substrate used": "Estrone 3-sulfate",
                "Cell System": "HEK293-OAT3",
                "Reference": "Kaufhold, 2011"
            },
            {
                "Inhibitor": "Alpha-ketoglutarate",
                "IC50 (μM)": 92.8,
                "Ki (μM)": null,
                "Substrate used": "Estrone 3-sulfate",
                "Cell System": "HEK293-OAT3",
                "Reference": "Kaufhold, 2011"
            },
            {
                "Inhibitor": "Betamipron",
                "IC50 (μM)": null,
                "Ki (μM)": 48.3,
                "Substrate used": "Estrone 3-sulfate",
                "Cell System": "S2-OAT3",
                "Reference": "Takeda, 2001"
            },
            {
                "Inhibitor": "Bumetanide",
                "IC50 (μM)": 0.75,
                "Ki (μM)": null,
                "Substrate used": "Estrone 3-sulfate",
                "Cell System": "S2-OAT3",
                "Reference": "Hasannejad, 2004"
            },
            {
                "Inhibitor": "Bumetanide",
                "IC50 (μM)": 7.8,
                "Ki (μM)": null,
                "Substrate used": "Estrone 3-sulfate",
                "Cell System": "OAT3-expressing oocytes",
                "Reference": "Elsby, 2011"
            },
            {
                "Inhibitor": "Bumetanide",
                "IC50 (μM)": 5.4,
                "Ki (μM)": null,
                "Substrate used": "Methotrexate",
                "Cell System": "OAT3-expressing oocytes",
                "Reference": "Elsby, 2011"
            },
            {
                "Inhibitor": "Candesartan",
                "IC50 (μM)": 0.3,
                "Ki (μM)": null,
                "Substrate used": "Uric acid",
                "Cell System": "HEK293-OAT3",
                "Reference": "Sato, 2008"
            },
            {
                "Inhibitor": "Cefadroxil",
                "IC50 (μM)": null,
                "Ki (μM)": 8620.0,
                "Substrate used": "Prostaglandin F2alpha",
                "Cell System": "S2-OAT3",
                "Reference": "Khamdang, 2003"
            },
            {
                "Inhibitor": "Cefamandole",
                "IC50 (μM)": null,
                "Ki (μM)": 50.0,
                "Substrate used": "Prostaglandin F2alpha",
                "Cell System": "S2-OAT3",
                "Reference": "Khamdang, 2003"
            },
            {
                "Inhibitor": "Cefazolin",
                "IC50 (μM)": null,
                "Ki (μM)": 550.0,
                "Substrate used": "Prostaglandin F2alpha",
                "Cell System": "S2-OAT3",
                "Reference": "Khamdang, 2003"
            },
            {
                "Inhibitor": "Cefoperazone",
                "IC50 (μM)": null,
                "Ki (μM)": 1890.0,
                "Substrate used": "Prostaglandin F2alpha",
                "Cell System": "S2-OAT3",
                "Reference": "Khamdang, 2003"
            },
            {
                "Inhibitor": "Cefotaxime",
                "IC50 (μM)": null,
                "Ki (μM)": 290.0,
                "Substrate used": "Prostaglandin F2alpha",
                "Cell System": "S2-OAT3",
                "Reference": "Khamdang, 2003"
            },
            {
                "Inhibitor": "Ceftriaxone",
                "IC50 (μM)": null,
                "Ki (μM)": 4390.0,
                "Substrate used": "Prostaglandin F2alpha",
                "Cell System": "S2-OAT3",
                "Reference": "Khamdang, 2003"
            },
            {
                "Inhibitor": "Cephaloridine",
                "IC50 (μM)": null,
                "Ki (μM)": 2460.0,
                "Substrate used": "Prostaglandin F2alpha",
                "Cell System": "S2-OAT3",
                "Reference": "Khamdang, 2003"
            },
            {
                "Inhibitor": "Cephalothin",
                "IC50 (μM)": null,
                "Ki (μM)": 40.0,
                "Substrate used": "Prostaglandin F2alpha",
                "Cell System": "S2-OAT3",
                "Reference": "Khamdang, 2003"
            },
            {
                "Inhibitor": "Chlorothiazide",
                "IC50 (μM)": 65.3,
                "Ki (μM)": null,
                "Substrate used": "Estrone 3-sulfate",
                "Cell System": "S2-OAT3",
                "Reference": "Hasannejad, 2004"
            },
            {
                "Inhibitor": "Cilastatin",
                "IC50 (μM)": null,
                "Ki (μM)": 231.0,
                "Substrate used": "Estrone 3-sulfate",
                "Cell System": "S2-OAT3",
                "Reference": "Takeda, 2001"
            },
            {
                "Inhibitor": "Cimetidine",
                "IC50 (μM)": 79.0,
                "Ki (μM)": null,
                "Substrate used": "Sitagliptin",
                "Cell System": "CHO-OAT3",
                "Reference": "Chu, 2007"
            },
            {
                "Inhibitor": "Citrinin",
                "IC50 (μM)": null,
                "Ki (μM)": 15.4,
                "Substrate used": "Ochratoxin A",
                "Cell System": "S2-OAT2",
                "Reference": "Jung, 2001"
            },
            {
                "Inhibitor": "Cyclothiazide",
                "IC50 (μM)": 27.9,
                "Ki (μM)": null,
                "Substrate used": "Estrone 3-sulfate",
                "Cell System": "S2-OAT3",
                "Reference": "Hasannejad, 2004"
            },
            {
                "Inhibitor": "Diclofenac",
                "IC50 (μM)": 7.78,
                "Ki (μM)": null,
                "Substrate used": "Estrone 3-sulfate",
                "Cell System": "S2-OAT3",
                "Reference": "Khamdang, 2002"
            },
            {
                "Inhibitor": "Ethacrynic acid",
                "IC50 (μM)": 0.58,
                "Ki (μM)": null,
                "Substrate used": "Estrone 3-sulfate",
                "Cell System": "S2-OAT3",
                "Reference": "Hasannejad, 2004"
            },
            {
                "Inhibitor": "Fenofibric acid",
                "IC50 (μM)": 2.2,
                "Ki (μM)": null,
                "Substrate used": "Sitagliptin",
                "Cell System": "CHO-OAT3",
                "Reference": "Chu, 2007"
            },
            {
                "Inhibitor": "Fluvastatin",
                "IC50 (μM)": 5.79,
                "Ki (μM)": null,
                "Substrate used": "Estrone 3-sulfate",
                "Cell System": "S2-OAT3",
                "Reference": "Takeda, 2004"
            },
            {
                "Inhibitor": "Furosemide",
                "IC50 (μM)": 7.31,
                "Ki (μM)": null,
                "Substrate used": "Estrone 3-sulfate",
                "Cell System": "S2-OAT3",
                "Reference": "Hasannejad, 2004"
            },
            {
                "Inhibitor": "Furosemide",
                "IC50 (μM)": 1.7,
                "Ki (μM)": null,
                "Substrate used": "Sitagliptin",
                "Cell System": "CHO-OAT3",
                "Reference": "Chu, 2007"
            },
            {
                "Inhibitor": "Gemfibrozil",
                "IC50 (μM)": 6.8,
                "Ki (μM)": null,
                "Substrate used": "Pravastatin",
                "Cell System": "S2-OAT3",
                "Reference": "Nakagomi-Hagihara, 2007"
            },
            {
                "Inhibitor": "Glutarate",
                "IC50 (μM)": 78.5,
                "Ki (μM)": null,
                "Substrate used": "Estrone 3-sulfate",
                "Cell System": "HEK293-OAT3",
                "Reference": "Kaufhold, 2011"
            },
            {
                "Inhibitor": "Hydrochlorothiazide",
                "IC50 (μM)": 942.0,
                "Ki (μM)": null,
                "Substrate used": "Estrone 3-sulfate",
                "Cell System": "S2-OAT3",
                "Reference": "Hasannejad, 2004"
            },
            {
                "Inhibitor": "Ibuprofen",
                "IC50 (μM)": 6.0,
                "Ki (μM)": null,
                "Substrate used": "Estrone 3-sulfate",
                "Cell System": "S2-OAT3",
                "Reference": "Khamdang, 2002"
            },
            {
                "Inhibitor": "Ibuprofen",
                "IC50 (μM)": 3.7,
                "Ki (μM)": null,
                "Substrate used": "Sitagliptin",
                "Cell System": "CHO-OAT3",
                "Reference": "Chu, 2007"
            },
            {
                "Inhibitor": "Indapamide",
                "IC50 (μM)": 11.0,
                "Ki (μM)": null,
                "Substrate used": "Sitagliptin",
                "Cell System": "CHO-OAT3",
                "Reference": "Chu, 2007"
            },
            {
                "Inhibitor": "Indomethacin",
                "IC50 (μM)": 0.61,
                "Ki (μM)": null,
                "Substrate used": "Estrone 3-sulfate",
                "Cell System": "S2-OAT3",
                "Reference": "Khamdang, 2002"
            },
            {
                "Inhibitor": "JBP485",
                "IC50 (μM)": 185.0,
                "Ki (μM)": 160.0,
                "Substrate used": "Bestatin",
                "Cell System": "HEK293-OAT3",
                "Reference": "Zhu, 2012"
            },
            {
                "Inhibitor": "Ketoprofen",
                "IC50 (μM)": 5.98,
                "Ki (μM)": null,
                "Substrate used": "Estrone 3-sulfate",
                "Cell System": "S2-OAT3",
                "Reference": "Khamdang, 2002"
            },
            {
                "Inhibitor": "Losartan",
                "IC50 (μM)": 1.6,
                "Ki (μM)": null,
                "Substrate used": "Uric acid",
                "Cell System": "HEK293-OAT3",
                "Reference": "Sato, 2008"
            },
            {
                "Inhibitor": "Mefenamic acid",
                "IC50 (μM)": 0.78,
                "Ki (μM)": null,
                "Substrate used": "Estrone 3-sulfate",
                "Cell System": "S2-OAT3",
                "Reference": "Khamdang, 2002"
            },
            {
                "Inhibitor": "Methazolamide",
                "IC50 (μM)": 97.5,
                "Ki (μM)": null,
                "Substrate used": "Estrone 3-sulfate",
                "Cell System": "S2-OAT3",
                "Reference": "Hasannejad, 2004"
            },
            {
                "Inhibitor": "Naproxen",
                "IC50 (μM)": 4.67,
                "Ki (μM)": null,
                "Substrate used": "Estrone 3-sulfate",
                "Cell System": "S2-OAT3",
                "Reference": "Khamdang, 2002"
            },
            {
                "Inhibitor": "Novobiocin",
                "IC50 (μM)": 4.99,
                "Ki (μM)": 4.77,
                "Substrate used": "Estrone 3-sulfate",
                "Cell System": "COS7-OAT3",
                "Reference": "Duan, 2009"
            },
            {
                "Inhibitor": "Octanoate",
                "IC50 (μM)": null,
                "Ki (μM)": 8.6,
                "Substrate used": "Ochratoxin A",
                "Cell System": "S2-OAT2",
                "Reference": "Jung, 2001"
            },
            {
                "Inhibitor": "Olmesartan",
                "IC50 (μM)": 0.027,
                "Ki (μM)": null,
                "Substrate used": "Uric acid",
                "Cell System": "HEK293-OAT3",
                "Reference": "Sato, 2008"
            },
            {
                "Inhibitor": "Para-aminohippurate",
                "IC50 (μM)": null,
                "Ki (μM)": 19.6,
                "Substrate used": "Ochratoxin A",
                "Cell System": "S2-OAT2",
                "Reference": "Jung, 2001"
            },
            {
                "Inhibitor": "Penicillin G",
                "IC50 (μM)": 102.0,
                "Ki (μM)": 88.0,
                "Substrate used": "Bestatin",
                "Cell System": "HEK293-OAT3",
                "Reference": "Zhu, 2012"
            },
            {
                "Inhibitor": "Phenacetin",
                "IC50 (μM)": 19.4,
                "Ki (μM)": null,
                "Substrate used": "Estrone 3-sulfate",
                "Cell System": "S2-OAT3",
                "Reference": "Khamdang, 2002"
            },
            {
                "Inhibitor": "Pimelate",
                "IC50 (μM)": 634.0,
                "Ki (μM)": null,
                "Substrate used": "Estrone 3-sulfate",
                "Cell System": "HEK293-OAT3",
                "Reference": "Kaufhold, 2011"
            },
            {
                "Inhibitor": "Piroxicam",
                "IC50 (μM)": 2.52,
                "Ki (μM)": null,
                "Substrate used": "Estrone 3-sulfate",
                "Cell System": "S2-OAT3",
                "Reference": "Khamdang, 2002"
            },
            {
                "Inhibitor": "Piroxicam",
                "IC50 (μM)": null,
                "Ki (μM)": 4.88,
                "Substrate used": "Ochratoxin A",
                "Cell System": "S2-OAT2",
                "Reference": "Jung, 2001"
            },
            {
                "Inhibitor": "Pratosartan",
                "IC50 (μM)": 0.095,
                "Ki (μM)": null,
                "Substrate used": "Uric acid",
                "Cell System": "HEK293-OAT3",
                "Reference": "Sato, 2008"
            },
            {
                "Inhibitor": "Pravastatin",
                "IC50 (μM)": 13.7,
                "Ki (μM)": null,
                "Substrate used": "Estrone 3-sulfate",
                "Cell System": "S2-OAT3",
                "Reference": "Takeda, 2004"
            },
            {
                "Inhibitor": "Probenecid*",
                "IC50 (μM)": 3.1,
                "Ki (μM)": null,
                "Substrate used": "Cimetidine",
                "Cell System": "CHO-OAT3",
                "Reference": "Chu, 2007"
            },
            {
                "Inhibitor": "Probenecid",
                "IC50 (μM)": null,
                "Ki (μM)": 32.0,
                "Substrate used": "Dimesna",
                "Cell System": "HeLa-OAT3",
                "Reference": "Cutler, 2012"
            },
            {
                "Inhibitor": "Probenecid*",
                "IC50 (μM)": null,
                "Ki (μM)": 9.0,
                "Substrate used": "Estrone 3-sulfate",
                "Cell System": "S2-OAT3",
                "Reference": "Takeda, 2001"
            },
            {
                "Inhibitor": "Probenecid*",
                "IC50 (μM)": null,
                "Ki (μM)": 1.3,
                "Substrate used": "Fexofenadine",
                "Cell System": "HEK293-OAT3",
                "Reference": "Tahara, 2006"
            },
            {
                "Inhibitor": "Probenecid*",
                "IC50 (μM)": null,
                "Ki (μM)": 4.41,
                "Substrate used": "Ochratoxin A",
                "Cell System": "S2-OAT3",
                "Reference": "Jung, 2001"
            },
            {
                "Inhibitor": "Probenecid*",
                "IC50 (μM)": 5.6,
                "Ki (μM)": null,
                "Substrate used": "Sitagliptin",
                "Cell System": "CHO-OAT3",
                "Reference": "Chu, 2007"
            },
            {
                "Inhibitor": "Quinapril",
                "IC50 (μM)": 6.2,
                "Ki (μM)": null,
                "Substrate used": "Sitagliptin",
                "Cell System": "CHO-OAT3",
                "Reference": "Chu, 2007"
            },
            {
                "Inhibitor": "Simvastatin",
                "IC50 (μM)": 32.3,
                "Ki (μM)": null,
                "Substrate used": "Estrone 3-sulfate",
                "Cell System": "S2-OAT3",
                "Reference": "Takeda, 2004"
            },
            {
                "Inhibitor": "Sitagliptin",
                "IC50 (μM)": 160.0,
                "Ki (μM)": null,
                "Substrate used": "Cimetidine",
                "Cell System": "CHO-OAT3",
                "Reference": "Chu, 2007"
            },
            {
                "Inhibitor": "Suberate",
                "IC50 (μM)": 232.0,
                "Ki (μM)": null,
                "Substrate used": "Estrone 3-sulfate",
                "Cell System": "HEK293-OAT3",
                "Reference": "Kaufhold, 2011"
            },
            {
                "Inhibitor": "Sulfasalazine",
                "IC50 (μM)": 3.0,
                "Ki (μM)": null,
                "Substrate used": "Methotrexate",
                "Cell System": "OAT3-expressing oocytes",
                "Reference": "Elsby, 2011"
            },
            {
                "Inhibitor": "Sulindac",
                "IC50 (μM)": 3.62,
                "Ki (μM)": null,
                "Substrate used": "Estrone 3-sulfate",
                "Cell System": "S2-OAT3",
                "Reference": "Khamdang, 2002"
            },
            {
                "Inhibitor": "Telmisartan",
                "IC50 (μM)": 1.6,
                "Ki (μM)": null,
                "Substrate used": "Uric acid",
                "Cell System": "HEK293-OAT3",
                "Reference": "Sato, 2008"
            },
            {
                "Inhibitor": "Trichloromethiazide",
                "IC50 (μM)": 71.2,
                "Ki (μM)": null,
                "Substrate used": "Estrone 3-sulfate",
                "Cell System": "S2-OAT3",
                "Reference": "Hasannejad, 2004"
            },
            {
                "Inhibitor": "Valsartan",
                "IC50 (μM)": 0.2,
                "Ki (μM)": null,
                "Substrate used": "Uric acid",
                "Cell System": "HEK293-OAT3",
                "Reference": "Sato, 2008"
            }
        ],
        "substrates": [
            {
                "Substrate": "Bumetanide*",
                "Km (μM)": "1586",
                "Cell System": "S2-OAT3",
                "Reference": "Hasannejad, 2004"
            },
            {
                "Substrate": "Cefaclor",
                "Km (μM)": "ND",
                "Cell System": "HEK293-OAT3",
                "Reference": "Ueo, 2005"
            },
            {
                "Substrate": "Ceftizoxime",
                "Km (μM)": "ND",
                "Cell System": "HEK293-OAT3",
                "Reference": "Ueo, 2005"
            },
            {
                "Substrate": "Cimetidine",
                "Km (μM)": "113",
                "Cell System": "HEK293-OAT3",
                "Reference": "Tahara, 2006"
            },
            {
                "Substrate": "Cimetidine",
                "Km (μM)": "174",
                "Cell System": "CHO-OAT3",
                "Reference": "Chu, 2007"
            },
            {
                "Substrate": "Cimetidine",
                "Km (μM)": "57.4",
                "Cell System": "OAT3-expressing oocytes",
                "Reference": "Cha, 2001"
            },
            {
                "Substrate": "Cortisol",
                "Km (μM)": "2.4",
                "Cell System": "OAT3-expressing oocytes",
                "Reference": "Asif, 2005"
            },
            {
                "Substrate": "Dimesna",
                "Km (μM)": "390",
                "Cell System": "HeLa-OAT3",
                "Reference": "Cutler, 2012"
            },
            {
                "Substrate": "Edaravone sulfate",
                "Km (μM)": "15.1",
                "Cell System": "HEK293-OAT3",
                "Reference": "Mizuno, 2007"
            },
            {
                "Substrate": "Estrone 3-sulfate",
                "Km (μM)": "2.18",
                "Cell System": "COS7-OAT3",
                "Reference": "Duan, 2009"
            },
            {
                "Substrate": "Estrone 3-sulfate",
                "Km (μM)": "2.21",
                "Cell System": "S2-OAT3",
                "Reference": "Takeda, 2001"
            },
            {
                "Substrate": "Estrone 3-sulfate",
                "Km (μM)": "3.1",
                "Cell System": "OAT3-expressing oocytes",
                "Reference": "Cha, 2001"
            },
            {
                "Substrate": "Estrone 3-sulfate",
                "Km (μM)": "6.3",
                "Cell System": "HEK293-OAT3",
                "Reference": "Ueo, 2005"
            },
            {
                "Substrate": "Estrone 3-sulfate",
                "Km (μM)": "7.5",
                "Cell System": "S2-OAT3",
                "Reference": "Takeda, 2000"
            },
            {
                "Substrate": "Fexofenadine",
                "Km (μM)": "70.2",
                "Cell System": "HEK293-OAT3",
                "Reference": "Tahara, 2006"
            },
            {
                "Substrate": "Furosemide*",
                "Km (μM)": "ND",
                "Cell System": "S2-OAT3",
                "Reference": "Hasannejad, 2004"
            },
            {
                "Substrate": "Methotrexate",
                "Km (μM)": "10.9",
                "Cell System": "OAT3-expressing oocytes",
                "Reference": "Cha, 2001"
            },
            {
                "Substrate": "Methotrexate",
                "Km (μM)": "17.2",
                "Cell System": "OAT3-expressing oocytes",
                "Reference": "Uwai, 2004"
            },
            {
                "Substrate": "Methotrexate",
                "Km (μM)": "21.1",
                "Cell System": "S2-OAT3",
                "Reference": "Takeda, 2002"
            },
            {
                "Substrate": "Ochratoxin A",
                "Km (μM)": "0.75",
                "Cell System": "S2-OAT3",
                "Reference": "Jung, 2001"
            },
            {
                "Substrate": "Olmesartan",
                "Km (μM)": "0.12",
                "Cell System": "HEK293-OAT3",
                "Reference": "Yamada, 2007"
            },
            {
                "Substrate": "Para-aminohippurate",
                "Km (μM)": "87.2",
                "Cell System": "OAT3-expressing oocytes",
                "Reference": "Cha, 2001"
            },
            {
                "Substrate": "Pitavastatin",
                "Km (μM)": "3.3",
                "Cell System": "OAT3-expressing oocytes",
                "Reference": "Fujino, 2005"
            },
            {
                "Substrate": "Pravastatin",
                "Km (μM)": "27.2",
                "Cell System": "S2-OAT3",
                "Reference": "Nakagomi-Hagihara, 2007"
            },
            {
                "Substrate": "Prostaglandin E2",
                "Km (μM)": "0.345",
                "Cell System": "S2-OAT3",
                "Reference": "Kimura, 2002"
            },
            {
                "Substrate": "Prostaglandin F2alpha",
                "Km (μM)": "1.092",
                "Cell System": "S2-OAT3",
                "Reference": "Kimura, 2002"
            },
            {
                "Substrate": "Rosuvastatin",
                "Km (μM)": "7.4",
                "Cell System": "OAT3-expressing oocytes",
                "Reference": "Windass, 2007"
            },
            {
                "Substrate": "Sitagliptin",
                "Km (μM)": "162",
                "Cell System": "CHO-OAT3",
                "Reference": "Chu, 2007"
            },
            {
                "Substrate": "Tetracycline",
                "Km (μM)": "566.2",
                "Cell System": "S2-OAT3",
                "Reference": "Babu, 2002"
            },
            {
                "Substrate": "Uric acid",
                "Km (μM)": "380.3",
                "Cell System": "HEK293-OAT3",
                "Reference": "Sato, 2008"
            },
            {
                "Substrate": "Zidovudine",
                "Km (μM)": "145",
                "Cell System": "S2-OAT3",
                "Reference": "Takeda, 2002"
            }
        ],
        "ddi": [
            {
                "DDI": "1",
                "Implicated Transporter": "OATs/OCTs",
                "Interacting Drug": "Cotrimoxazole (trimethoprim/sulfamethoxazole)",
                "Affected Drug": "Apricitabine",
                "AUC": "1.7",
                "Cmax": "1.3",
                "CLR": "0.6",
                "CL/F": "0.6",
                "t1/2": "1.4",
                "Effect on PD": "ND",
                "Reference": "Shiveley, 2008",
                "More Details": "DDI 1"
            },
            {
                "DDI": "2",
                "Implicated Transporter": "OATs/OCTs",
                "Interacting Drug": "Cotrimoxazole (trimethoprim/sulfamethoxazole)",
                "Affected Drug": "Zidovudine",
                "AUC": "NS",
                "Cmax": "ND",
                "CLR": "0.4",
                "CL/F": "NS",
                "t1/2": "NS",
                "Effect on PD": "ND",
                "Reference": "Chatton, 1992",
                "More Details": "DDI 2"
            },
            {
                "DDI": "3",
                "Implicated Transporter": "OATs",
                "Interacting Drug": "Furosemide",
                "Affected Drug": "Lomefloxacin",
                "AUC": "1.1",
                "Cmax": "NS",
                "CLR": "0.7",
                "CL/F": "0.9",
                "t1/2": "NS",
                "Effect on PD": "ND",
                "Reference": "Sudoh, 1994",
                "More Details": "DDI 3"
            },
            {
                "DDI": "4",
                "Implicated Transporter": "OATs",
                "Interacting Drug": "Probenecid",
                "Affected Drug": "Acyclovir",
                "AUC": "1.4",
                "Cmax": "ND",
                "CLR": "0.7",
                "CL/F": "NS",
                "t1/2": "ND",
                "Effect on PD": "ND",
                "Reference": "Laskin, 1982",
                "More Details": "DDI 4"
            },
            {
                "DDI": "5",
                "Implicated Transporter": "OATs",
                "Interacting Drug": "Probenecid",
                "Affected Drug": "Cefaclor",
                "AUC": "2.1",
                "Cmax": "1.5",
                "CLR": "ND",
                "CL/F": "ND",
                "t1/2": "1.6",
                "Effect on PD": "ND",
                "Reference": "Welling, 1979",
                "More Details": "DDI 5"
            },
            {
                "DDI": "6",
                "Implicated Transporter": "OATs",
                "Interacting Drug": "Probenecid",
                "Affected Drug": "Cefonicid",
                "AUC": "2.1",
                "Cmax": "1.2",
                "CLR": "0.3",
                "CL/F": "ND",
                "t1/2": "1.5",
                "Effect on PD": "ND",
                "Reference": "Pitkin, 1981",
                "More Details": "DDI 6"
            },
            {
                "DDI": "7",
                "Implicated Transporter": "OATs",
                "Interacting Drug": "Probenecid",
                "Affected Drug": "Cefoxitin",
                "AUC": "2.4",
                "Cmax": "ND",
                "CLR": "0.4",
                "CL/F": "ND",
                "t1/2": "2.0",
                "Effect on PD": "ND",
                "Reference": "Vlasses, 1980",
                "More Details": "DDI 7"
            },
            {
                "DDI": "8",
                "Implicated Transporter": "OATs",
                "Interacting Drug": "Probenecid",
                "Affected Drug": "Ceftriaxone",
                "AUC": "0.7",
                "Cmax": "ND",
                "CLR": "ND",
                "CL/F": "1.3",
                "t1/2": "0.8",
                "Effect on PD": "ND",
                "Reference": "Stoeckel, 1988",
                "More Details": "DDI 8"
            },
            {
                "DDI": "9",
                "Implicated Transporter": "OATs",
                "Interacting Drug": "Probenecid",
                "Affected Drug": "Cephradine",
                "AUC": "2.4",
                "Cmax": "1.9",
                "CLR": "ND",
                "CL/F": "ND",
                "t1/2": "1.5",
                "Effect on PD": "ND",
                "Reference": "Welling, 1979",
                "More Details": "DDI 9"
            },
            {
                "DDI": "10",
                "Implicated Transporter": "OATs",
                "Interacting Drug": "Probenecid",
                "Affected Drug": "Cidofovir",
                "AUC": "ND",
                "Cmax": "ND",
                "CLR": "0.5",
                "CL/F": "0.6",
                "t1/2": "ND",
                "Effect on PD": "ND",
                "Reference": "Cundy, 1995",
                "More Details": "DDI 10"
            },
            {
                "DDI": "11",
                "Implicated Transporter": "OATs/MRPs",
                "Interacting Drug": "Probenecid",
                "Affected Drug": "Ciprofloxacin",
                "AUC": "1.7",
                "Cmax": "NS",
                "CLR": "0.4",
                "CL/F": "0.6",
                "t1/2": "1.5",
                "Effect on PD": "ND",
                "Reference": "Jaehde, 1995",
                "More Details": "DDI 11"
            },
            {
                "DDI": "12",
                "Implicated Transporter": "OATs",
                "Interacting Drug": "Probenecid",
                "Affected Drug": "Dicloxacillin",
                "AUC": "1.9",
                "Cmax": "1.8",
                "CLR": "0.3",
                "CL/F": "0.5",
                "t1/2": "ND",
                "Effect on PD": "ND",
                "Reference": "Beringer, 2008",
                "More Details": "DDI 12"
            },
            {
                "DDI": "13",
                "Implicated Transporter": "OATs",
                "Interacting Drug": "Probenecid",
                "Affected Drug": "Famotidine",
                "AUC": "1.8",
                "Cmax": "1.5",
                "CLR": "0.4",
                "CL/F": "0.1",
                "t1/2": "NS",
                "Effect on PD": "ND",
                "Reference": "Inotsume, 1990",
                "More Details": "DDI 13"
            },
            {
                "DDI": "14",
                "Implicated Transporter": "OATs/MRPs",
                "Interacting Drug": "Probenecid",
                "Affected Drug": "Furosemide",
                "AUC": "2.7",
                "Cmax": "1.5",
                "CLR": "0.3",
                "CL/F": "0.4",
                "t1/2": "1.7",
                "Effect on PD": "ND",
                "Reference": "Vree, 1995",
                "More Details": "DDI 14"
            }
        ]
    }
}